Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel polypeptide

a polypeptide and polypeptide technology, applied in the field of new polypeptides, can solve the problems of difficult to synthesize sialyl lewis x sugar chain with 2,3-siaryltransferase, unknown enzyme, and above enzymes that have not been identified, and achieve the effect of efficiently secreting and efficiently secreting

Inactive Publication Date: 2008-01-17
KYOWA HAKKO KIRIN CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

Enables the targeted synthesis of Lewis x and Lewis y sugar chains on proteins, enhancing their targeting to specific tissues like cancer cells or the liver, improving diagnostic and therapeutic applications, including cancer treatment and infertility management.

Problems solved by technology

Since α2,3-siaryltransferase has low activity to add sialic acid to the Lewis x sugar chain, it is difficult to synthesize sialyl Lewis x sugar chain with α2,3-siaryltransferase.
However, such an enzyme is still unknown.
Nevertheless, the above enzymes have not been identified yet.
However, with the enzymological analysis, it is impossible to identify respective α1,3-fucosyltransferases expressed in a cell or tissue expressing multiple α1,3-fucosyltransferase, and to clarify the enzymologic characteristic of each α1,3-fucosyltransferase.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel polypeptide
  • Novel polypeptide
  • Novel polypeptide

Examples

Experimental program
Comparison scheme
Effect test

example 1

Cloning of a Novel Mouse α1,3-Fucosyltransferase Gene (cDNA)

(1) Preparation of mRNA from Mouse Brain

[0341] About 30 μg of mRNA was prepared from BALB / c mouse brain using a mRNA extractor kit, Oligotex™-dT30 (manufactured by Roche). Reagents and methods were employed as described in the instructions attached to the kit.

(2) Construction of a Mouse Brain cDNA Library

[0342] Using 8 μg of mRNA obtained from the mouse brain in (1) above and a kit (SUPERSCRIPT Choice System for cDNA Synthesis manufactured by GIBCO BRL), double-stranded cDNAs were synthesized with oligo-dT as primers.

[0343] SfiI linkers were ligated to the both ends of the double-stranded cDNAs as described below.

[Addition of Sfi I Linker]

[0344] A single-stranded DNA represented by SEQ ID NO:6 and a single stranded DNA represented by SEQ ID NO:7 were synthesized using a 380A DNA synthesizer (manufactured by Applied Biosystems).

[0345] Each of the synthesized single-stranded DNAs 50 μg was independently dissolved in...

example 2

Synthesis of the Lewis x Sugar Chain and the Lewis y Sugar Chain in a Human Culture Cell into which a Mouse Fuc-TIX Expression Plasmid Obtained in Example 1 has been Introduced

[0390] A control plasmid (pAMo) and a mouse Fuc-TIX expression plasmid (pAMo-mFT9) were separately dissolved in TE buffer to 1 μg / μl, introduced into Namalwa cells by electroporation method, thereby obtaining transformed cells.

[0391] The transformed cells were subjected to indirect fluorescent antibody staining using an anti-Lewis x sugar chain antibodies (PM-81 or 73-30), an anti-Lewis y sugar chain antibody (AH-6), and an anti-sialyl Lewis x sugar chain antibody (KM93).

[0392] Indirect fluorescent antibody staining was performed according to the methods described in Example 1 (3). When compared to the cells into which pAMo had been introduced, the cells into which pAMo-mFT9 had been introduced showed an approximately 20-fold increase in reactivity (peak value of histogram) against each of the anti-Lewis x ...

example 3

In Vitro Substrate Specificity of Mouse Fuc-TIX

[0402] In vitro substrate specificity of Fuc-TIX encoded by the mouse Fuc-TIX cDNA obtained in Example 1 was examined as follows.

[0403] To express the mouse Fuc-TIX in animal cells, the mouse Fuc-TIX cDNA was subcloned into an expression vector pCDM8 for animal cells as described below.

[0404] That is, a 1.2-kb HindIII-AseI fragment containing an open reading frame (ORF) of the mouse Fuc-TIX cDNA was isolated from pAMo-mFT9. The cut ends were blunt-ended with T4 DNA polymerase, then subcloned into an EcoRV site of pBluescript SK(−).

[0405] A plasmid, in which the cDNA was subcloned in a direction such that the 5′ and 3′ sides of the cDNA was present near HindIII and PstI sites of the cloning sites, respectively, was selected. The plasmid was excised with HindIII and PstI to isolate a 1.2-kb fragment containing the mouse Fuc-TIX cDNA.

[0406] The 1.2-kb fragment was subcloned between HindIII and PstI of pCDM8 to construct a mouse Fuc-TI...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

This invention relates to a novel polypeptide having an α1,3-fucosyltransferase activity, a method for producing the polypeptide, a DNA encoding the polypeptide, a method for producing the DNA, a recombinant vector obtained by inserting the DNA thereinto, a transformant having the recombinant vector, an antibody recognizing the polypeptide, a method for determining or immunostaining the polypeptide of the present invention using the antibody, a method for producing a fucose-containing sugar chain using the polypeptide or the transformant, a method for screening a substance that changes the expression of a gene encoding the polypeptide, a method for screening a substance that changes the activity of the polypeptide, and a method for diagnosing diseases such as encephalopathy, renal diseases and cancers.

Description

TECHNICAL FIELD [0001] The present invention relates to a novel polypeptide having α1,3-fucosyltransferase activity, a method for producing the polypeptide, a DNA encoding the polypeptide, a recombinant vector into which the DNA is integrated, a transformant having the recombinant vector, an antibody recognizing the polypeptide, a method for producing a fucose-containing sugar chain and a complex carbohydrate containing the sugar chain using the polypeptide, and a method for producing a fucose-containing sugar chain and a complex carbohydrate containing the sugar chain using a transformant having the recombinant vector. BACKGROUND ART [0002] It is thought that fucose-containing sugar chains are not only associated with such vital phenomena as development, differentiation and cell recognition, but are also associated with the onset and progression of inflammations, cancers, autoimmune diseases and many other diseases (Edited by Akira KOHATA, Senichiro HAKOMORI, Katsutaka NAGAI, Glyco...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/7088A01K67/027A61P35/00C07H21/00C07H21/04C07K16/44C12P1/00C12P19/00C12Q1/02C12Q1/68G01N33/50G01N33/53C12N1/21C12N9/10C12N15/54C12P19/04C12P19/26C12P21/00
CPCA01K67/0275A01K2217/05C12N9/1051C12P19/04Y10T436/143333C12P21/005C12Q1/6883C12Q2600/158C12P19/26A61P35/00
Inventor NARIMATSU, HISASHIKUDO, TAKASHISASAKI, KATSUTOSHI
Owner KYOWA HAKKO KIRIN CO LTD